使用基于体素的阿尔茨海默病特异性区域分析系统来区分阿尔茨海默病和重度抑郁症患者

Takahiro Tokumasu, Y. Okajima, O. Takashio, Masayuki Tani, T. Izuno, D. Ikuse, Teppei Morita, Gosuke Arai, Nobuyuki Saga, K. Hori, T. Gokan, H. Matsuda, A. Iwanami
{"title":"使用基于体素的阿尔茨海默病特异性区域分析系统来区分阿尔茨海默病和重度抑郁症患者","authors":"Takahiro Tokumasu, Y. Okajima, O. Takashio, Masayuki Tani, T. Izuno, D. Ikuse, Teppei Morita, Gosuke Arai, Nobuyuki Saga, K. Hori, T. Gokan, H. Matsuda, A. Iwanami","doi":"10.4172/2168-975X.1000196","DOIUrl":null,"url":null,"abstract":"Background: Recently, voxel-based morphometry (VBM) has become a popular tool for the early diagnosis of Alzheimer’s disease (AD). The voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) is a clinically useful VBM technique that employs magnetic resonance imaging (MRI) to automatically detect the loss of Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation gray matter volume in the medial temporal lobe. \nObjective: To investigate the utility of VSRAD for differentiating between AD and major depressive disorder (MDD), and to identify the neuropathological differences between the two groups. \nMethods: The subjects included 18 patients with MDD (mean ± standard deviation: 74.8 ± 7.1 years, 4 males and 14 females) and 31 patients with AD (82.4 ± 7.3 years, 7 males and 24 females). Three-dimensional T1-weighted sagittal images, were acquired using a 1.5Tesla MRI device and analyzed using the VSRAD advance software, parahippocampal atrophy was represented as a Z-score. Neuropsychological tests consisted of the Patient Health Questionnaire 9, Hamilton Rating Scale for Depression, Global Assessment of Function and Mini-Mental State Examination (MMSE). Correlations between the Z-score and the neuropsychological test scores were statistically examined. \nResults: Patients with AD had significantly higher Z-scores than did patients with MDD (1.99 ± 1.27 vs. 1.11 ± 0.49, p 2 were all diagnosed as AD. In the AD group, the Z-scores were significantly correlated with the MMSE scores throughout the study period (0 weeks: p=0.015, 24 weeks: p=0.024), whereas no significant correlations between the Z-scores and MMSE were observed for the MDD group. Conclusion: Our results obtained using the VSRAD suggest that VSRAD is useful for differentiating between AD and MDD, which is important, as the these two diseases are often difficult to diagnose based solely on their symptoms. Such findings imply that VSRAD may become a useful auxiliary diagnostic tool.","PeriodicalId":9146,"journal":{"name":"Brain disorders & therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Differentiating between Patients with Alzheimer's Disease and Patients with Major Depressive Disorder Using the Voxel-based Specific Regional Aanalysis System for Alzheimer's Disease\",\"authors\":\"Takahiro Tokumasu, Y. Okajima, O. Takashio, Masayuki Tani, T. Izuno, D. Ikuse, Teppei Morita, Gosuke Arai, Nobuyuki Saga, K. Hori, T. Gokan, H. Matsuda, A. Iwanami\",\"doi\":\"10.4172/2168-975X.1000196\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Recently, voxel-based morphometry (VBM) has become a popular tool for the early diagnosis of Alzheimer’s disease (AD). The voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) is a clinically useful VBM technique that employs magnetic resonance imaging (MRI) to automatically detect the loss of Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation gray matter volume in the medial temporal lobe. \\nObjective: To investigate the utility of VSRAD for differentiating between AD and major depressive disorder (MDD), and to identify the neuropathological differences between the two groups. \\nMethods: The subjects included 18 patients with MDD (mean ± standard deviation: 74.8 ± 7.1 years, 4 males and 14 females) and 31 patients with AD (82.4 ± 7.3 years, 7 males and 24 females). Three-dimensional T1-weighted sagittal images, were acquired using a 1.5Tesla MRI device and analyzed using the VSRAD advance software, parahippocampal atrophy was represented as a Z-score. Neuropsychological tests consisted of the Patient Health Questionnaire 9, Hamilton Rating Scale for Depression, Global Assessment of Function and Mini-Mental State Examination (MMSE). Correlations between the Z-score and the neuropsychological test scores were statistically examined. \\nResults: Patients with AD had significantly higher Z-scores than did patients with MDD (1.99 ± 1.27 vs. 1.11 ± 0.49, p 2 were all diagnosed as AD. In the AD group, the Z-scores were significantly correlated with the MMSE scores throughout the study period (0 weeks: p=0.015, 24 weeks: p=0.024), whereas no significant correlations between the Z-scores and MMSE were observed for the MDD group. Conclusion: Our results obtained using the VSRAD suggest that VSRAD is useful for differentiating between AD and MDD, which is important, as the these two diseases are often difficult to diagnose based solely on their symptoms. Such findings imply that VSRAD may become a useful auxiliary diagnostic tool.\",\"PeriodicalId\":9146,\"journal\":{\"name\":\"Brain disorders & therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-10-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain disorders & therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2168-975X.1000196\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain disorders & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2168-975X.1000196","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

背景:近年来,基于体素的形态学(VBM)已成为阿尔茨海默病(AD)早期诊断的一种流行工具。基于体素的阿尔茨海默病特定区域分析系统(VSRAD)是一种临床有用的VBM技术,它采用磁共振成像(MRI)来自动检测Aries系统公司内侧颞叶灰质体积的损失。目的:探讨VSRAD在AD与重度抑郁障碍(MDD)鉴别中的应用价值,并探讨两组的神经病理差异。方法:纳入18例重度抑郁症患者(平均±标准差:74.8±7.1岁,男性4例,女性14例)和31例AD患者(82.4±7.3岁,男性7例,女性24例)。使用1.5特斯拉MRI设备获取三维t1加权矢状图像,并使用VSRAD高级软件进行分析,海马体旁萎缩用z分数表示。神经心理测试包括患者健康问卷9、汉密尔顿抑郁评定量表、整体功能评估和简易精神状态检查(MMSE)。Z-score与神经心理测试分数之间的相关性进行统计学检验。结果:AD患者的z评分显著高于MDD患者(1.99±1.27∶1.11±0.49,p < 2),均为AD。在AD组中,z得分与MMSE得分在整个研究期间显著相关(0周:p=0.015, 24周:p=0.024),而在MDD组中,z得分与MMSE之间没有显著相关性。结论:我们使用VSRAD获得的结果表明,VSRAD可用于区分AD和MDD,这一点很重要,因为这两种疾病通常难以仅根据其症状进行诊断。这些发现表明,VSRAD可能成为有用的辅助诊断工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Differentiating between Patients with Alzheimer's Disease and Patients with Major Depressive Disorder Using the Voxel-based Specific Regional Aanalysis System for Alzheimer's Disease
Background: Recently, voxel-based morphometry (VBM) has become a popular tool for the early diagnosis of Alzheimer’s disease (AD). The voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) is a clinically useful VBM technique that employs magnetic resonance imaging (MRI) to automatically detect the loss of Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation gray matter volume in the medial temporal lobe. Objective: To investigate the utility of VSRAD for differentiating between AD and major depressive disorder (MDD), and to identify the neuropathological differences between the two groups. Methods: The subjects included 18 patients with MDD (mean ± standard deviation: 74.8 ± 7.1 years, 4 males and 14 females) and 31 patients with AD (82.4 ± 7.3 years, 7 males and 24 females). Three-dimensional T1-weighted sagittal images, were acquired using a 1.5Tesla MRI device and analyzed using the VSRAD advance software, parahippocampal atrophy was represented as a Z-score. Neuropsychological tests consisted of the Patient Health Questionnaire 9, Hamilton Rating Scale for Depression, Global Assessment of Function and Mini-Mental State Examination (MMSE). Correlations between the Z-score and the neuropsychological test scores were statistically examined. Results: Patients with AD had significantly higher Z-scores than did patients with MDD (1.99 ± 1.27 vs. 1.11 ± 0.49, p 2 were all diagnosed as AD. In the AD group, the Z-scores were significantly correlated with the MMSE scores throughout the study period (0 weeks: p=0.015, 24 weeks: p=0.024), whereas no significant correlations between the Z-scores and MMSE were observed for the MDD group. Conclusion: Our results obtained using the VSRAD suggest that VSRAD is useful for differentiating between AD and MDD, which is important, as the these two diseases are often difficult to diagnose based solely on their symptoms. Such findings imply that VSRAD may become a useful auxiliary diagnostic tool.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信